JOURNAL OF NEUROLOGIE NEUROSURGERY AND PSYCHIATRYOral levosimendan in amyotrophic lateral sclerosis: a phase II multicentre, randomised, double-blind, placebo-controlled trial. Getting older, getting worse: menopause as a turning-point for women living with multiple sclerosis.
